Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors.
Tong
D
D
Kucera
E
E
Schuster
E
E
Schmutzler
R K
RK
Swoboda
H
H
Reinthaller
A
A
Leodolter
S
S
Zeillinger
R
R
D024682:BRCA2 Protein; D001706:Biopsy; D001943:Breast Neoplasms / Q000097:blood / Q000235:genetics* / Q000473:pathology; D002874:Chromosome Mapping; D002898:Chromosomes, Human, Pair 8; D004247:DNA / Q000097:blood; D004273:DNA, Neoplasm / Q000032:analysis; D016889:Endometrial Neoplasms / Q000097:blood / Q000235:genetics / Q000473:pathology; D005260:Female; D019398:Genes, BRCA1; D016158:Genes, p53; D005819:Genetic Markers; D006258:Head and Neck Neoplasms / Q000097:blood / Q000235:genetics / Q000473:pathology; D006801:Humans; D019656:Loss of Heterozygosity; D018895:Microsatellite Repeats; D009363:Neoplasm Proteins / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000097:blood / Q000235:genetics* / Q000473:pathology; D014157:Transcription Factors / Q000235:genetics*
D024682:BRCA2 Protein; D004273:DNA, Neoplasm; D005819:Genetic Markers; D009363:Neoplasm Proteins; D014157:Transcription Factors; D004247:DNA